HealthQuill Health
Novartis, one of the world’s top five pharmaceutical companies by revenue, has filed a lawsuit against two US government health agencies, terming drug price negotiations initiated by them as “unconstitutional.”
Drugs Health Pharma

Novartis takes US government to court on drug price negotiations

HQ Team September 2, 2023: Novartis, one of the world’s top five pharmaceutical companies by revenue, has filed a lawsuit against two US.

Read More
Roche’s atezolizumab drug Tecentriq, to treat cancer, was approved by Britain’s Medicines and Healthcare Products Regulatory Agency.
Drugs Health Pharma

Roche’s under-the-skin cancer injection gets Britain’s nod 

HQ Team August 30, 2023: Roche’s atezolizumab drug Tecentriq, to treat cancer, was approved by Britain’s Medicines and Healthcare Products Regulatory Agency. Tecentriq.

Read More
The US government, for the first time, has started negotiating prices of prescription drugs directly with companies in a bid to lower healthcare costs under an Inflation Reduction Act.
Drugs Health Pharma

US starts talks on drug prices with 10 companies for the first time 

HQ Team August 30, 2023: The US government, for the first time, has started negotiating prices of prescription drugs directly with companies in.

Read More
Takeda Pharmaceutical’s subsidiary, Shire Plc., was granted an FDA nod for making generic chewable tablets to treat attention-deficit, hyperactivity disorder, and moderate to severe binge disorder in adults.
Drugs Health Pharma

First generic versions of Japan’s Takeda ADHD tabs gets FDA nod

HQ Team August 29, 2023: The US Food and Drug Administration has approved several first generics of Takeda Pharmaceutical subsidiary, Shire Plc’s Vyvanse.

Read More
American-Irish pharmaceutical company, Mallinckrodt Pharmaceuticals, and its “certain” subsidiaries have filed for a second bankruptcy in the US after reaching a pact with their creditors to cut the opioid-related settlement payments by about $1 billion.
Drugs Health Pharma

Opioid hit Mallinckrodt files for 2nd bankruptcy, plaintiffs may lose

HQ Team August 28, 2023: American-Irish pharmaceutical company, Mallinckrodt Pharmaceuticals, and its “certain” subsidiaries have filed for a second bankruptcy in the US after.

Read More
Global warming may wipe out canopies in tropical forests, with plants no longer able to combine light, CO2, and water to make the sugars that sustain them, according to an international study.
Climate Health Pharma

Forest canopies may die out if global warming continues

HQ Team August 27, 2023: Global warming may wipe out canopies in tropical forests, with plants no longer able to combine light, CO2,.

Read More
Climate Health Uncategorized

Eco-friendly paper straws contain harmful “Forever chemicals,” new study reveals

HQ team August 26, 2023: A new study conducted by Belgian researchers has raised concerns about the safety of so-called “eco-friendly” paper drinking.

Read More
A surge in diagnosis of eight-year-old children has led to an increase in autism cases in the US, even as inequalities in the tests of the disorder persist, according to a report.
Health Medical

Sedentary behavior in youth linked to potential cardiac risks, finds study

HQ Team August 26, 2023: Technology is an insidious part of our lifestyles, especially for the younger generation, which learns to hold a.

Read More
SARS-CoV-2 can damage organs such as the heart, brain, kidney, and blood vessels and not the lungs alone, according to a study by global researchers.
Drugs Health Pharma

Covid-19 virus scars heart, brain, kidney: International study reveals

HQ Team August 25, 2023: SARS-CoV-2 can damage organs such as the heart, brain, kidney, and blood vessels and not the lungs alone,.

Read More
The US drug regulator gave its nod for Sandoz Inc., an arm of Sweden-based Novartis and which is set to be Europe’s largest generic drugmaker, for a biosimilar, Tyruko, to treat adults with multiple sclerosis.
Drugs Health Pharma

USFDA green lights Sandoz’s biosimilar Tyruko to treat multiple sclerosis  

HQ Team August 25, 2023: The US drug regulator gave its nod for Sandoz Inc., an arm of Sweden-based Novartis and which is.

Read More
X